These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27925155)

  • 1. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
    Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
    Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
    J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
    Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
    J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
    Khan S; Subedi D; Chowdhury MM
    Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
    Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
    Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
    Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
    Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of subclinical skin manifestation in patients with psoriasis and psoriatic arthritis by fluorescence optical imaging.
    Schmidt A; Glimm AM; Haugen IK; Hoff P; Schmittat G; Burmester GR; Klotsche J; Ohrndorf S
    Arthritis Res Ther; 2020 Aug; 22(1):192. PubMed ID: 32811543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of hand muscle volume and composition in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
    Friedberger A; Figueiredo C; Grimm A; d'Oliveira I; Bäuerle T; Rech J; Kleyer A; Simon D; Uder M; Schett G; Engelke K
    BMC Musculoskelet Disord; 2020 Apr; 21(1):203. PubMed ID: 32241261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
    Solomon DH; Love TJ; Canning C; Schneeweiss S
    Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.
    Nas K; Karkucak M; Durmus B; Karatay S; Capkın E; Kaya A; Ucmak D; Akar ZA; Cevik R; Kilic E; Kilic G; Ozgocmen S
    Int J Rheum Dis; 2015 Nov; 18(8):873-9. PubMed ID: 26173043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
    Loganathan A; Kamalaraj N; El-Haddad C; Pile K
    Int J Rheum Dis; 2021 Sep; 24(9):1112-1120. PubMed ID: 34076348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
    Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
    Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population.
    Bhole VM; Choi HK; Burns LC; Vera Kellet C; Lacaille DV; Gladman DD; Dutz JP
    Rheumatology (Oxford); 2012 Mar; 51(3):552-6. PubMed ID: 22120603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.